Monitor for any further C-suite departures or restructuring announcements as Doherty's retirement approaches in mid-2027. No near-term catalyst from this filing.
Price Chart
Executive Summary
Quest Diagnostics announced that EVP Catherine T. Doherty will retire in July 2027, transitioning to a new role overseeing health systems, the Corewell Health JV, and Project Nova effective November 1, 2026. Her compensation remains unchanged at a $650,000 base salary with an $1,200,000 RSU grant. This is a routine succession planning filing with no immediate financial impact.
Key Facts
- Catherine T. Doherty will retire in July 2027
- Effective November 1, 2026, she transitions to EVP role overseeing health systems, Corewell Health JV, and Project Nova
- Annual base salary remains $650,000
- Target annual incentive remains 80% of base salary
- Equity award of $1,200,000 in RSUs granted November 3, 2026 under the Employee Long-Term Incentive Plan
Financial Impact
No material financial impact; compensation terms unchanged from prior arrangements.
Risk Factors
- Potential loss of institutional knowledge when Doherty departs in 2027
- Project Nova execution risk during leadership transition
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000947871-26-000922 |
| Document: 0000947871-26-000922-index-headers.html | 0000947871-26-000922 |
| Document: 0000947871-26-000922-index.html | 0000947871-26-000922 |
| Document: 0000947871-26-000922.txt | 0000947871-26-000922 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 5d ago | Institutional Cluster | $245.62 | awaiting T+60 | awaiting T+60 | $251.82 (+2.52%) |
Oct 26, 2026 6d ago | 144 | $242.95 | awaiting T+60 | awaiting T+60 | $251.82 (+3.65%) |
Oct 22, 2026 10d ago | 8-K | $243.28 | awaiting T+60 | awaiting T+60 | $251.82 (+3.51%) |
Oct 22, 2026 10d ago | 8-K | $243.28 | awaiting T+60 | awaiting T+60 | $251.82 (+3.51%) |
Oct 6, 2026 26d ago | 8-K | $227.06 | awaiting T+60 | awaiting T+60 | $251.82 (+10.90%) |
Sep 22, 2026 5w ago | Press Release | $233.00 | awaiting T+60 | awaiting T+60 | $251.82 (+8.08%) |
Sep 9, 2026 7w ago | Press Release | $231.14 | awaiting T+60 | awaiting T+60 | $251.82 (+8.95%) |
Sep 3, 2026 8w ago | Insider Cluster | $236.26 | awaiting T+60 | awaiting T+60 | $251.82 (+6.59%) |
Jul 23, 2026 14w ago | 8-K | $227.90 $239.15 | ▲ +4.94% | ▲ +0.38% | $251.82 (+10.50%) |
May 8, 2026 25w ago | 8-K | $189.81 $235.84 | ▲ +24.25% | ▲ +19.86% | $251.82 (+32.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers